1
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Mariette C, Piessen G and Triboulet JP:
Therapeutic strategies in oesophageal carcinoma: Role of surgery
and other modalities. Lancet Oncol. 8:545–553. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Ell C and Lorenz D: Diagnosis and
treatment of oesophageal carcinoma: Changes in every respect.
Viszeralmedizin. 31:3142015.PubMed/NCBI
|
5
|
Acunzo M and Croce CM: MicroRNA in Cancer
and Cachexia-A Mini-Review. J Infect Dis. 212 Suppl 1:S74–S77.
2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li S, Qin X, Li Y, Zhang X, Niu R, Zhang
H, Cui A, An W and Wang X: MiR-133a suppresses the migration and
invasion of esophageal cancer cells by targeting the EMT regulator
SOX4. Am J Transl Res. 7:1390–1403. 2015.PubMed/NCBI
|
9
|
Mao Y, Li L, Liu J, Wang L and Zhou Y:
MiR-495 inhibits esophageal squamous cell carcinoma progression by
targeting Akt1. Oncotarget. 7:51223–51236. 2016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Llambi F and Green DR: Apoptosis and
oncogenesis: Give and take in the BCL-2 family. Curr Opin Genet
Dev. 21:12–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fulda S, Meyer E and Debatin KM:
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
Oncogene. 21:2283–2294. 2002. View Article : Google Scholar : PubMed/NCBI
|
12
|
Thoms HC, Dunlop MG and Stark LA:
p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4
stimulates nucleolar translocation of RelA and apoptosis in
colorectal cancer cells. Cancer Res. 67:1660–1669. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Törmänen-Näpänkangas U, Soini Y, Kahlos K,
Kinnula V and Pääkkö P: Expression of caspases-3, −6 and −8 and
their relation to apoptosis in non-small cell lung carcinoma. Int J
Cancer. 93:192–198. 2001. View
Article : Google Scholar : PubMed/NCBI
|
14
|
Li YH, Wang C, Meng K, Chen LB and Zhou
XJ: Influence of survivin and caspase-3 on cell apoptosis and
prognosis in gastric carcinoma. World J Gastroenterol.
10:1984–1988. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Li SX, Chai L, Cai ZG, Jin LJ, Chen Y, Wu
HR and Sun Z: Expression of survivin and caspase 3 in oral squamous
cell carcinoma and peritumoral tissue. Asian Pac J Cancer Prev.
13:5027–5031. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Nassar A, Lawson D, Cotsonis G and Cohen
C: Survivin and caspase-3 expression in breast cancer: Correlation
with prognostic parameters, proliferation, angiogenesis, and
outcome. Appl Immunohistochem Mol Morphol. 16:113–120. 2008.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Hsia JY, Chen CY, Chen JT, Hsu CP, Shai
SE, Yang SS, Chuang CY, Wang PY and Miaw J: Prognostic significance
of caspase-3 expression in primary resected esophageal squamous
cell carcinoma. Eur J Surg Oncol. 29:44–48. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Chen J, Yang H, Wen J, Luo K, Liu Q, Huang
Y, Zheng Y, Tan Z, Huang Q and Fu J: NHE9 induces chemoradiotherapy
resistance in esophageal squamous cell carcinoma by upregulating
the Src/Akt/β-catenin pathway and Bcl-2 expression. Oncotarget.
6:12405–12420. 2015. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hendrickson AW, Meng XW and Kaufmann SH:
Anticancer therapy: Boosting the bang of Bim. J Clin Invest.
118:3582–3584. 2008. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Youle RJ and Strasser A: The BCL-2 protein
family: Opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Stauber RH, Mann W and Knauer SK: Nuclear
and cytoplasmic survivin: Molecular mechanism, prognostic, and
therapeutic potential. Cancer Res. 67:5999–6002. 2007. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang X, Wang C, Shan S, Liu X, Jiang Z
and Ren T: TLR4/ROS/miRNA-21 pathway underlies lipopolysaccharide
instructed primary tumor outgrowth in lung cancer patients.
Oncotarget. 7:42172–42182. 2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Xicola RM, Bontu S, Doyle BJ, Rawson J,
Garre P, Lee E, de la Hoya M, Bessa X, Clofent J, Bujanda L, et al:
Association of a let-7 miRNA binding region of TGFBR1 with
hereditary mismatch repair proficient colorectal cancer (MSS
HNPCC). Carcinogenesis. 37:751–758. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bimonte S, Leongito M, Barbieri A, Del
Vecchio V, Falco M, Giudice A, Palaia R, Albino V, Di Giacomo R,
Petrillo A, et al: The therapeutic targets of miRNA in hepatic
cancer stem cells. Stem Cells Int. 2016:10652302016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF,
Huang Q, Fang GQ and Li EM: MiRNA profile in esophageal squamous
cell carcinoma: Downregulation of miR-143 and miR-145. World J
Gastroenterol. 17:79–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chen Z, Li J, Tian L, Zhou C, Gao Y, Zhou
F, Shi S, Feng X, Sun N, Yao R, et al: MiRNA expression profile
reveals a prognostic signature for esophageal squamous cell
carcinoma. Cancer Lett. 350:34–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
27
|
Kong KL, Kwong DL, Chan TH, Law SY, Chen
L, Li Y, Qin YR and Guan XY: MicroRNA-375 inhibits tumour growth
and metastasis in oesophageal squamous cell carcinoma through
repressing insulin-like growth factor 1 receptor. Gut. 61:33–42.
2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Winther M, Alsner J, Tramm T, Baeksgaard
L, Holtved E and Nordsmark M: Evaluation of miR-21 and miR-375 as
prognostic biomarkers in esophageal cancer. Acta Oncol.
54:1582–1591. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Cui XB, Li S, Li TT, Peng H, Jin TT, Zhang
SM, Liu CX, Yang L, Shen YY, Li SG, et al: Targeting oncogenic
PLCE1 by miR-145 impairs tumor proliferation and metastasis of
esophageal squamous cell carcinoma. Oncotarget. 7:1777–1795. 2016.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Nie W, Song W, Zhang W, Wang Y, Zhu A,
Shao J and Guan X: miR-1470 mediates lapatinib induced p27
upregulation by targeting c-jun. J Cell Physiol. 230:1630–1639.
2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Banday MZ, Sameer AS, Mir AH, Mokhdomi TA,
Chowdri NA and Haq E: Matrix metalloproteinase (MMP)-2, −7 and −9
promoter polymorphisms in colorectal cancer in ethnic Kashmiri
population-A case-control study and a mini review. Gene. 589:81–89.
2016. View Article : Google Scholar : PubMed/NCBI
|
32
|
Serra R, Grande R, Gallelli L, Rende P,
Scarcello E, Buffone G, Caliò FG, Gasbarro V, Amato B and de
Franciscis S: Carotid body paragangliomas and matrix
metalloproteinases. Ann Vasc Surg. 28:1665–1670. 2014. View Article : Google Scholar : PubMed/NCBI
|
33
|
Muñoz-Espín D and Serrano M: Cellular
senescence: From physiology to pathology. Nat Rev Mol Cell Biol.
15:482–496. 2014. View
Article : Google Scholar : PubMed/NCBI
|